6,500,000 ORDINARY SHARES AND PRE-FUNDED WARRANTS SCISPARC LTD. UNDERWRITING AGREEMENTUnderwriting Agreement • August 14th, 2023 • SciSparc Ltd. • Pharmaceutical preparations • New York
The undersigned, SciSparc Ltd., a company organized under the laws of Israel (collectively with its Subsidiaries (as defined below), if any, the “Company”), hereby confirms its agreement (this “Agreement”) with Aegis Capital Corp. (the “Underwriter”) on the terms and conditions set forth herein.
PRE-FUNDED ORDINARY SHARE PURCHASE WARRANT SCISPARC LTD.Pre-Funded Ordinary Share Purchase Warrant • August 14th, 2023 • SciSparc Ltd. • Pharmaceutical preparations
THIS PRE-FUNDED ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _________________________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after __________, 2023 (the “Issue Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from SciSparc Ltd., a company organized under the laws of Israel (the “Company”), up to _______________________________ Ordinary Shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company. The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
